{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T06:56:11Z","timestamp":1785826571382,"version":"3.56.0"},"reference-count":41,"publisher":"Scientific Scholar","content-domain":{"domain":["ijdvl.com"],"crossmark-restriction":true},"short-container-title":["IJDVL"],"abstract":"Background:<\/jats:title>Erythema nodosum leprosum (ENL) is a frequent complication of multibacillary leprosy that can result in significant morbidity, including peripheral nerve damage and physical disability. The identification of possible serum markers could be a valuable tool for the early detection of ENL.<\/jats:p><\/jats:sec>Aims:<\/jats:title>The purpose of this study was to evaluate selected serum mediators involved in the innate and adaptive immune responses to identify possible immunomarkers for ENL.<\/jats:p><\/jats:sec>Methods:<\/jats:title>The levels of interleukin-2, interleukin-4, interleukin-6, interleukin-10, interleukin-17, interferon-\u03b3, tumor necrosis factor, nitric oxide and anti-phenolic glycolipid-I antibodies were measured in the sera of leprosy patients with ENL [at the beginning of reaction (M0) and 1 month later (M1)], and then compared with the levels of the same markers in patients with untreated multibacillary leprosy without ENL (controls with leprosy: CTRL) and healthy individuals (healthy controls: CTRH).<\/jats:p><\/jats:sec>Results:<\/jats:title>Significantly higher levels of serum interleukin-6 were observed in M0 than in CTRL. In addition, pairwise comparisons showed higher levels of interleukin-6 in M0 compared to M1. Levels of tumor necrosis factor were higher in M0 than in CTRL, with no significant difference between M0 and M1. There were no differences in the levels of interleukin-2, interleukin-4, interleukin-10, interleukin-17 or interferon-\u03b3 between groups. The CTRL group had higher levels of nitric oxide compared to M0 and M1. High levels of anti-phenolic glycolipid-I were observed in M0, M1 and CTRL than in CTRH.<\/jats:p><\/jats:sec>Limitations:<\/jats:title>Three patients were not assessed at M1, decreasing the number of evaluated patients from 14 to 11.<\/jats:p><\/jats:sec>Conclusion:<\/jats:title>High-serum levels of interleukin-6 were observed during ENL, primarily in patients with more severe reactions; levels decreased after specific therapy, suggesting a role for this cytokine in pathogenesis and its utility as an ENL biomarker. Further studies should explore whether interleukin-6 could also be used as a predictive marker for ENL or as a specific target for its treatment.<\/jats:p><\/jats:sec>","DOI":"10.25259\/ijdvl_143_20","type":"journal-article","created":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T10:40:44Z","timestamp":1615372844000},"page":"190-198","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Increased serum levels of interleukin-6 in erythema nodosum leprosum suggest its use as a biomarker"],"prefix":"10.25259","volume":"87","author":[{"given":"F\u00e1tima Regina","family":"Vilani-Moreno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e2nia Nieto","family":"Brito-de-Souza","sequence":"additional","affiliation":[{"name":"Immunology Team, Lauro de Souza Lima Institute, Bauru, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f4nia Maria Us\u00f3 Ruiz","family":"Silva","sequence":"additional","affiliation":[{"name":"Microbiology Team, Lauro de Souza Lima Institute, Bauru, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana Sierra Ass\u00eancio Almeida","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz Gomes Carreira","family":"Sartori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula","family":"Campanelli","sequence":"additional","affiliation":[{"name":"Bauru School of Dentistry, University of S\u00e3o Paulo, Bauru, Brazil,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaison Antonio","family":"Barreto","sequence":"additional","affiliation":[{"name":"Epidemiology Service, Lauro de Souza Lima Institute, Bauru, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos da Cunha Lopes","family":"Virmond","sequence":"additional","affiliation":[{"name":"Rehabilitation Team, Lauro de Souza Lima Institute, Bauru, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2021,3,23]]},"reference":[{"key":"10.25259\/IJDVL_143_20\/ref-1","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.jaad.2014.03.034","article-title":"Recognizing and managing the immunologic reactions in leprosy","volume":"71","author":"Kamath","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.25259\/IJDVL_143_20\/ref-2","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1128\/CMR.19.2.338-381.2006","article-title":"The continuing challenges of leprosy","volume":"19","author":"Scollard","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"10.25259\/IJDVL_143_20\/ref-3","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.trstmh.2008.01.004","article-title":"Towards understanding the pathology of erythema nodosum leprosum","volume":"102","author":"Kahawita","year":"2008","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.25259\/IJDVL_143_20\/ref-4","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.4049\/jimmunol.149.4.1470","article-title":"Cytokine patterns of immunologically mediated tissue damage","volume":"149","author":"Yamamura","year":"1992","journal-title":"J Immunol"},{"key":"10.25259\/IJDVL_143_20\/ref-5","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1046\/j.1365-2567.1998.00634.x","article-title":"Lepromatous leprosy patients show T helper 1 like cytokine profile with differencial expression of interleukin 10 during type 1 and 2 reactions","volume":"95","author":"Sreenivasan","year":"1998","journal-title":"Immunology"},{"key":"10.25259\/IJDVL_143_20\/ref-6","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1046\/j.1365-3083.1999.00622.x","article-title":"Cytokine mRNA expression in leprosy: A possible role for interferon gamma and interleukin 12 in reactions (RR and ENL)","volume":"50","author":"Moraes","year":"1999","journal-title":"Scand J Immunol"},{"key":"10.25259\/IJDVL_143_20\/ref-7","first-page":"626","article-title":"Lessons of leprosy: The emergence of TH17 cytokines during type II reactions (ENL) is teaching us about T cell plasticity","volume":"11","author":"Martiniuk","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"10.25259\/IJDVL_143_20\/ref-8","doi-asserted-by":"publisher","first-page":"e0004592","DOI":"10.1371\/journal.pntd.0004592","article-title":"Leprosy reactions show increased Th17 cell activity and reduced FOXP3+ Tregs with concomitant decrease in TGF \u03b2 and increase in IL 6","volume":"10","author":"Saini","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"10.25259\/IJDVL_143_20\/ref-9","doi-asserted-by":"publisher","first-page":"e0196853","DOI":"10.1371\/journal.pone.0196853","article-title":"In situ T regulatory cells and Th17 cytokines in paired samples of leprosy type 1 and type 2 reactions","volume":"13","author":"Costa","year":"2018","journal-title":"PLoS One"},{"key":"10.25259\/IJDVL_143_20\/ref-10","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1007\/s10875-012-9747-3","article-title":"Increased serum circulatory levels of interleukin 17F in type 1 reactions of leprosy","volume":"32","author":"Chaitanya","year":"2012","journal-title":"J Clin Immunol"},{"key":"10.25259\/IJDVL_143_20\/ref-11","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s00403-014-1486-2","article-title":"Serum Th17 cytokines in leprosy: Correlation with circulating CD4(+) CD25 (high) FoxP3 (+) T regs cells, as well as down regulatory cytokines","volume":"306","author":"Attia","year":"2014","journal-title":"Arch Dermatol Res"},{"key":"10.25259\/IJDVL_143_20\/ref-12","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s00430-017-0519-9","article-title":"Simultaneous analysis of multiple T helper subsets in leprosy reveals distinct patterns of Th1, Th2, Th17 and Tregs markers expression in clinical forms and reactional events","volume":"206","author":"Azevedo","year":"2017","journal-title":"Med Microbiol Immunol"},{"key":"10.25259\/IJDVL_143_20\/ref-13","first-page":"255","article-title":"Classification of leprosy according to immunity. A five group system","volume":"34","author":"Ridley","year":"1966","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"10.25259\/IJDVL_143_20\/ref-14","doi-asserted-by":"publisher","first-page":"333","DOI":"10.47276\/lr.87.3.332","article-title":"The development of a severity scale for Erythema Nodosum Leprosum-The ENLIST ENL severity scale","volume":"87","author":"Walker","year":"2016","journal-title":"Lepr Rev"},{"key":"10.25259\/IJDVL_143_20\/ref-15","doi-asserted-by":"crossref","first-page":"7764","DOI":"10.1073\/pnas.78.12.7764","article-title":"Nitrite biosynthesis in man","volume":"18","author":"Green","year":"1981","journal-title":"Proc Natl Acad Sci"},{"key":"10.25259\/IJDVL_143_20\/ref-16","first-page":"476","article-title":"Use of synthetic glycoconjugates containing the Mycobacterium leprae specific and immunodominant epitope of phenolic glycolipid I in the serology of leprosy","volume":"64","author":"Brett","year":"1986","journal-title":"Clin Exp Immunol"},{"key":"10.25259\/IJDVL_143_20\/ref-17","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1111\/j.1365-3156.2007.01951.x","article-title":"Utility of measuring serum levels of anti PGL I antibody, neopterin and C reactive protein in monitoring leprosy patients during multidrug treatment and reactions","volume":"12","author":"Silva","year":"2007","journal-title":"Trop Med Int Health"},{"key":"10.25259\/IJDVL_143_20\/ref-18","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12865-015-0118-8","article-title":"The imbalance between Tregs, Th17 cells and inflammatory cytokines among renal transplant recipients","volume":"16","author":"Ma","year":"2015","journal-title":"BMC Immunol"},{"key":"10.25259\/IJDVL_143_20\/ref-19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cyto.2015.01.014","article-title":"Association of TNF \u03b1(308(GG)), IL 10( 819(TT)), IL 10( 1082(GG)) and IL 1R1(+1970(CC)) genotypes with the susceptibility and progression of leprosy in North Indian population","volume":"73","author":"Tarique","year":"2015","journal-title":"Cytokine"},{"key":"10.25259\/IJDVL_143_20\/ref-20","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.cyto.2017.05.020","article-title":"Cytokines as biomarkers to monitoring the impact of multidrug therapy in immune response of leprosy patients","volume":"97","author":"Cassirer Costa","year":"2017","journal-title":"Cytokine"},{"key":"10.25259\/IJDVL_143_20\/ref-21","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/978-1-61779-539-8_29","article-title":"Cytokine measurement using cytometric bead arrays","volume":"845","author":"Castillo","year":"2012","journal-title":"Methods Mol Biol"},{"key":"10.25259\/IJDVL_143_20\/ref-22","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1574-695X.1999.tb01312.x","article-title":"Serum neopterin as a marker for reactional states in leprosy","volume":"24","author":"Hamerlinck","year":"1999","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.25259\/IJDVL_143_20\/ref-23","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1365-2249.2007.03485.x","article-title":"Serum levels of interferon gamma, tumour necrosis factor alpha, soluble interleukin 6R and soluble cell activation markers for monitoring response to treatment of leprosy reactions","volume":"150","author":"Iyer","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.25259\/IJDVL_143_20\/ref-24","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1046\/j.1365-2249.1998.00510.x","article-title":"Pentoxifylline decreases in vivo and in vitro tumour necrosis factor alpha (TNF alpha) production in lepromatous leprosy patients with erythema nodosum leprosum (ENL)","volume":"111","author":"Sampaio","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.25259\/IJDVL_143_20\/ref-25","doi-asserted-by":"publisher","first-page":"223","DOI":"10.47276\/lr.78.3.223","article-title":"Circulating cytokine profiles in leprosy patients","volume":"78","author":"Belgaumkar","year":"2007","journal-title":"Lepr Rev"},{"key":"10.25259\/IJDVL_143_20\/ref-26","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/1471-2334-9-75","article-title":"Potential plasma markers of Type 1 and Type 2 leprosy reactions: A preliminary report","volume":"9","author":"Stefani","year":"2009","journal-title":"BMC Infect Dis"},{"key":"10.25259\/IJDVL_143_20\/ref-27","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/infdis\/168.2.408","article-title":"The influence of thalidomide on the clinical and immunologic manifestation of erythema nodosum leprosum","volume":"168","author":"Sampaio","year":"1993","journal-title":"J Infect Dis"},{"key":"10.25259\/IJDVL_143_20\/ref-28","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1093\/infdis\/jis208","article-title":"Genetic and immunological evidence implicates interleukin 6 as a susceptibility gene for leprosy type 2 reaction","volume":"205","author":"Sousa","year":"2012","journal-title":"J Infect Dis"},{"key":"10.25259\/IJDVL_143_20\/ref-29","doi-asserted-by":"publisher","first-page":"e0005754","DOI":"10.1371\/journal.pntd.0005754","article-title":"Genetic polymorphisms of the IL6 and NOD2 genes are risk factors for inflammatory reactions in leprosy","volume":"11","author":"Sales Marques","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.25259\/IJDVL_143_20\/ref-30","doi-asserted-by":"publisher","first-page":"518","DOI":"10.4269\/ajtmh.2005.72.518","article-title":"A randomized, double blind, double dummy, controlled dose comparison of thalidomide for treatment of erythema nodosum leprosum","volume":"72","author":"Villahermosa","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"10.25259\/IJDVL_143_20\/ref-31","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3389\/fimmu.2017.00233","article-title":"A systematic review of immunological studies of erythema nodosum leprosum","volume":"8","author":"Polycarpou","year":"2017","journal-title":"Front Immunol"},{"key":"10.25259\/IJDVL_143_20\/ref-32","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1365-2249.1991.tb08131.x","article-title":"Serum levels of tumour necrosis factor alpha and interleukin 1 beta during leprosy reactional states","volume":"84","author":"Sarno","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"10.25259\/IJDVL_143_20\/ref-33","first-page":"218","article-title":"Correlation between TNF production, increase of plasma C reactive protein level and suppression of T lymphocyte response to concanavalin A during erythema nodosum leprosum","volume":"61","author":"Foss","year":"1993","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"10.25259\/IJDVL_143_20\/ref-34","doi-asserted-by":"publisher","first-page":"371","DOI":"10.47276\/lr.82.4.371","article-title":"Serum cytokine profile in leprosy and its correlation with clinico histopathological profile","volume":"82","author":"Madan","year":"2011","journal-title":"Lepr Rev"},{"key":"10.25259\/IJDVL_143_20\/ref-36","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1046\/j.1523-1747.2000.00158.x","article-title":"Anti inflammatory drugs block cytokine mRNA accumulation in the skin and improve the clinical condition of reactional leprosy patients","volume":"115","author":"Moraes","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.25259\/IJDVL_143_20\/ref-37","first-page":"61","article-title":"Comparison of pentoxifylline, thalidomide and prednisone in the treatment of ENL","volume":"66","author":"Moreira","year":"1998","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"10.25259\/IJDVL_143_20\/ref-38","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1086\/498216","article-title":"Effective treatment of erythema nodosum leprosum with thalidomide is associated with immune stimulation","volume":"192","author":"Haslett","year":"2005","journal-title":"J Infect Dis"},{"key":"10.25259\/IJDVL_143_20\/ref-39","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1590\/S0037-86822004000500003","article-title":"Erythema nodosum leprosum case series report: Clinical profile, immunological basis and treatment implemented in health services","volume":"37","author":"Guerra","year":"2004","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.25259\/IJDVL_143_20\/ref-40","first-page":"356","article-title":"Assessment of anti PGL I as a prognostic marker of leprosy reaction","volume":"66","author":"Stefani","year":"1998","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"10.25259\/IJDVL_143_20\/ref-41","first-page":"211","article-title":"Changes in circulating antibody levels to the major phenolic glycolipid during erythema nodosum leprosum in leprosy patients","volume":"53","author":"Andreoli","year":"1985","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"10.25259\/IJDVL_143_20\/ref-42","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/1523-1747.ep12354963","article-title":"IgM and IgG antibodies to phenolic glycolipid I from Mycobacterium leprae in leprosy: Insight into patient monitoring, erythema nodosum leprosum, and bacillary persistence","volume":"86","author":"Levis","year":"1986","journal-title":"J Invest Dermatol"}],"container-title":["Indian Journal of Dermatology, Venereology and Leprology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ijdvl.com\/increased-serum-levels-of-interleukin-6-in-erythema-nodosum-leprosum-suggest-its-use-as-a-biomarker\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ijdvl.com\/increased-serum-levels-of-interleukin-6-in-erythema-nodosum-leprosum-suggest-its-use-as-a-biomarker\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T20:58:04Z","timestamp":1698008284000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ijdvl.com\/increased-serum-levels-of-interleukin-6-in-erythema-nodosum-leprosum-suggest-its-use-as-a-biomarker\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,23]]},"references-count":41,"alternative-id":["10.25259\/IJDVL_143_20"],"URL":"https:\/\/doi.org\/10.25259\/ijdvl_143_20","relation":{},"ISSN":["0378-6323"],"issn-type":[{"value":"0378-6323","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,23]]},"article-number":"190"}}